Reference Product decision [Regulatives / Guidelines]

posted by Tina – India, 2013-04-22 13:40 (4427 d 03:42 ago) – Posting: # 10452
Views: 7,277

Should a European Reference Product be always used for MRP/DCP? If the innovator is the European Reference Product and is not available in a member state, can the generic (which had compared itself with the ERP) available in the member state be used for MRP/DCP application with the member state as the RMS? If the generic is marketed only in one member state, it would have been the company's decision to market in that MS. However, they have still compared with the innovator?

Does EMA require only a innovator to be compared as the reference?

Thanks in advance for the guidance.

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
41 visitors (0 registered, 41 guests [including 27 identified bots]).
Forum time: 17:23 CEST (Europe/Vienna)

No rational argument will have a rational effect on a man
who does not want to adopt a rational attitude.    Karl R. Popper

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5